Asahi Kasei Corporation (Headquarters: Tokyo, Japan) is the leading manufacturer and supplier of functional pharma excipients, such as microcrystalline cellulose, in Japan. In order to further address the rising demands in formulation research, we are now developing a cutting-edge pharma excipient primarily for injections: hyaluronic acid nanogel, Sonanos™. The Sonanos™ can act as a DDS carrier, facilitating sustained release or solubility enhancement of APIs. For more information, please visit https://www.ceolus.com/en/sonanos/hyaluronic_acid_nanogel/

In an era of accelerating change, Exponent is the only premium engineering and scientific consulting firm with the depth and breadth of expertise to solve our clients’ most profoundly unique, unprecedented, and urgent challenges. Exponent brings together 90+ technical disciplines and 950+ consultants to help our clients navigate the increasing complexity of more than a dozen industries, connecting decades of pioneering work in failure analysis to develop solutions for a safer, healthier, more sustainable world. For more information, go to: https://www.exponent.com/

MMG is a full-service patient recruitment agency that has helped clinical trial programs of all sizes accelerate their enrollment goals for almost four decades.  Through our data-driven strategies, and MMG’s “ME” program that closes the gaps in health equity and access, we are trusted leaders in trial recruitment and pride ourselves in our expertise. MMG’s “me” is a method powered by over 20 years of community-focused outreach to deliver clinical trial recruitment that overcomes critical enrollment barriers and achieves appropriate representation. MMG is a member of the world's largest healthcare communications network, Omnicom Health Group (OHG). The clinical trials we support benefit from our access to OHG's cutting-edge communication solutions and coveted partnerships in research, analytics, and digital technologies, as well as The Omnicom Group's vast buying power. For more information, go to mmgct.com. 

EmVenio Research, a PCM Trials Company, provides a scalable network of clinical trial sites strategically located in underrepresented communities to engage a diverse patient demographic. Our extensive global network comprises highly skilled clinicians, leading principal investigators, and cutting-edge research sites, allowing us to deliver high-quality clinical research services that prioritize reducing the burden on patient participation. For more information, go to https://emvenio.com/

Dandelion Health is a health technology company advancing precision in clinical AI and therapeutic development. Dandelion’s Precision Medicine platform delivers novel clinical insights at scale from rich, multimodal patient data and validated clinical AI -- enabling AI, medical device and life sciences companies to accelerate the entire product development lifecycle, improving clinical outcomes and enhancing patient lives. Founded by the world’s leading experts in healthcare and AI, Dandelion is built in partnership with a diverse consortium of leading healthcare systems from across the United States. To learn more, go to https://dandelionhealth.ai/

BENTO BIOLOGY PLATFORMS has created a new playbook to move the needle on clinical trial accrual, trial completion and equitable patient-finding so the drugs and therapies patients need can come to market as soon as possible. BENTO transforms clinical trial participation into an immersive user experience, capable of ensuring that participation in clinical trials is accessible and inclusive, from the comfort of of participants’ homes, with an engine for building trust in distrustful communities. Bento’s play-to-learn (P2L) and participate-to-earn (P2E) incentive platform, coupled with Bento’s marketplace of self-service biosampling tools and kitting software, distinguish it from other decentralized clinical trial (DCT) companies and legacy CROs. Well-designed digital token incentives gamify medication education, improve inclusion, mobilize enrollment, and accelerate time-to-endpoint. 100% of end users report BENTO Experience makes it easy to participate and increases participants’ desire to complete trial tasks. In 2024, Bento received the Patient Empowerment Platform of the year, as well as a prestigious “Federal 100” technology award for advancing health equity. For more information, go to https://www.bentobio.com/

Joymed Technology is a leading Contract Development and Manufacturing Organization (CDMO) in the medical device industry, dedicated to providing comprehensive research and development, clinical trial, regulatory approval, and contract manufacturing services for global medical device companies and clinical institutions.

For more information, please visit https://www.joymedtech.com/

Vibrent Health is at the cutting edge of applying digital technology for genomics enabled clinical research and precision medicine. Designed with a patient-centric focus, Vibrent’s unified data platform streamlines patient engagement, e-consent, data collection and analysis. Featuring EHR integration, remote biospecimen collection, and participant-centric apps, Vibrent drives secure, inclusive, and efficient research. For more information, go to https://www.vibrenthealth.com/

Antares Health Products Inc. (Antares) is leading supplier of vitamin E TPGS, a powerful tool in the formulation of pharmaceuticals, dietary supplements, food and beverage, personal care, and animal nutrition and health products. Antares produces TPGS in a manufacturing facility that meets current Good Manufacturing Practices (cGMP). The Antares Team combines proven, strong and diverse expertise in the manufacturing and applications of TPGS. Our Team works in close partnership with customers to meet their needs with high-quality product coupled with full technical support and customer service. For more information, visit https://www.tpgs.com/

PhaseV is a technology company leveraging advanced causal inference and machine learning to innovate clinical trials. Our technology and methods enable to optimize trial design by detecting hidden signals in existing clinical data and extracting actionable insights, as well as supporting advanced adaptive designs for more efficient, precise and successful clinical trials. For more information, go to www.phasevtrials.com

WCG is at the forefront of accelerating clinical research worldwide, serving as the trusted and preferred partner to biopharmaceutical and medical device companies, contract research organizations (CROs), research institutions, and site partners. Offering a unique combination of expertise, next-generation data and insights, and tech-enabled solutions, WCG reduces complexity and optimizes study operations and outcomes while maintaining the highest standards of human participant protection. For more than 55 years, WCG has maintained a relentless commitment to efficiency, safety, and impact, empowering clinical trials to deliver life-improving therapies swiftly. For more information, please visit wcgclinical.com or follow us on LinkedIn or X @WCGClinical.

Entos Pharmaceuticals Inc. is a clinical-stage genetic medicines company headquartered in Canada, with offices in the USA and UK. Entos leverages its proprietary Fusogenix™ platform in its own drug development programs and multiple licenses with pharmaceutical companies. Most recently, Entos partnered with Lilly to develop CNS and PNS-targeted genetic therapies. Learn more at www.entospharma.com